Top Biotechnology & Medical Research stocks in North America

Researchers and developers of biotechnology based drugs and therapies as well as medical devices and procedures that are at an early (non-commercial) stage.

Name
Market Cap
Price to Earnings
TTM
Dividend Yield
% TTM
us flag iconRVMDRevolution Medicines$7.21bnn/an/a
us flag iconRETAReata Pharmaceuticals$6.52bnn/an/a
us flag iconLEGNLegend Biotech$6.29bnn/an/a
us flag iconBPMCBlueprint Medicines$5.66bnn/an/a
us flag iconCRLCharles River Laboratories International$5.63bn26.84n/a
us flag iconVRNAVerona Pharma$5.54bnn/an/a
us flag iconISEEIVERIC bio$5.51bnn/an/a
us flag iconNUVLNuvalent$5.26bnn/an/a
us flag iconKRYSKrystal Biotech$4.86bn40.24n/a
us flag iconCYTKCytokinetics$4.82bnn/an/a
us flag iconIONSIonis Pharmaceuticals$4.72bnn/an/a
us flag iconALKSAlkermes$4.59bn12.64n/a
us flag iconSYNHSyneos Health$4.46bn28.55n/a
us flag iconALPNAlpine Immune Sciences$4.46bnn/an/a
us flag iconPCVXVaxcyte$4.24bnn/an/a
us flag iconMRTXMirati Therapeutics$4.12bnn/an/a
us flag iconALKSVAlkermes$4.05bn18.02n/a
us flag iconRYZBRayzebio$3.81bnn/an/a
us flag iconCBAYCymaBay Therapeutics$3.73bnn/an/a
us flag iconSLNOSoleno Therapeutics$3.63bnn/an/a